Technology for treating HPV infected patient

A patient and technology technology, applied in the direction of mammalian medical raw materials, pharmaceutical formulations, aerosol delivery, etc., can solve the problem of no definite treatment for HPV infection, and achieve the effect of improving the cure rate

Pending Publication Date: 2021-08-31
海南启研干细胞抗衰老医院有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no definite treatment for HPV infection. How to quickly turn HPV positi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Technology for treating HPV infected patient
  • Technology for treating HPV infected patient
  • Technology for treating HPV infected patient

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0028] Intravenous infusion of autologous NK cells for HPV-positive patients (a course of treatment for 2 consecutive times, the total number of cells is 1-1.6ⅹ16 10 , 1 time / day), combined with local intravaginal perfusion of NK cell culture fluid gel (a course of 7 consecutive times, 1 time / day) treatment, followed up 1, 3, and 6 months after the end of the course of treatment to observe the negative situation of HPV, The comprehensive effective rate is 86.5%.

[0029] case two

[0030] Intravenous infusion of autologous NK cells for HPV-positive patients (a course of treatment for 2 consecutive times, the total number of cells is 1-1.6ⅹ16 10 , 1 time / day), cooperate with multi-point injection of autologous NK cells in the vagina and cervix (a course of treatment is 2 consecutive times, the total number of cells is 1-2ⅹ16 9 , 1 time / day), intravaginally perfused with NK cell culture fluid gel for 5 days, followed up 1, 3, and 6 months after the course of treatment to obser...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of disease treatment, in particular to a technology for treating HPV (human papillomavirus) infected patients, which improves the cure rate of HPV positive patients. The NK cell adoptive immunotherapy is applied to control and treatment of HPV positive patients.

Description

technical field [0001] The invention relates to the technical field of disease treatment, in particular to a technique for treating patients with HPV infection. Background technique [0002] Cervical cancer is a common malignant tumor in women. Epidemiological and molecular biological data show that human papillomavirus (Human Papilloma Virus, HPV) infection is closely related to cervical cancer. Cervical cancer screening can reduce the risk of cervical cancer, but it cannot prevent HPV infection. At present, there is no definite treatment for HPV infection. How to quickly turn HPV positive patients negative is an important means to block HPV infection and prevent cervical cancer. [0003] In the vast majority of female groups, although they have been infected with HPV, they still have sufficient immune defense mechanisms to stimulate cellular immunity, humoral immunity, etc. to clear the virus. Studies have shown that DC cells, NK cells, etc. participate in the innate imm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K35/17A61K9/06A61P31/20
CPCA61K35/17A61K9/06A61K9/0034A61P31/20
Inventor 陶其强李文瑞王娅莎黄国军吕品雷蒙玲莉姚春媛
Owner 海南启研干细胞抗衰老医院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap